Becton Dickinson and Co
NYSE:BDX
Becton Dickinson and Co
NYSE:BDX
Price:
163.88
USD
-0.95%
Market Closed
Market Cap:
$46.7B
Relative Value
The Relative Value of one
BDX
stock under the Base Case scenario is
265.68
USD.
Compared to the current market price of 163.88 USD,
Becton Dickinson and Co
is
Undervalued by 38%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BDX
Relative Value
Base Case
265.68
USD
Undervaluation 38%
Multiples Across Competitors
BDX Competitors Multiples
Becton Dickinson and Co Competitors
Becton Dickinson and Co Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46.7B USD | 2.1 | 26.6 | 10.4 | 17.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192B USD | 4.3 | 29.4 | 16.9 | 23.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172.5B USD | 17.1 | 60.4 | 45.8 | 56.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
137.2B USD | 5.5 | 42.3 | 21.5 | 26 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
115.4B USD | 3.3 | 25 | 13.7 | 20 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.8B USD | 5.2 | 35.8 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.1B EUR | 1.9 | 21.2 | 11.8 | 16.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.8B USD | 8.2 | 46.4 | 25.6 | 28 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47.7B USD | 11.1 | 45.1 | 32 | 35.4 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36B USD | 6.7 | 24.2 | 17.1 | 19 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
33.1B USD | 1.6 | 15.9 | 11.4 | 13.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
